💊
Cinryze
C1 inhibitor (human)
Angioedemi ereditari
✅ Autorizzato
✅
Nessun allarme attivo
Questo medicinale non presenta carenze in corso, lettere di sicurezza o richiami.
A cosa serve
Treatment and pre-procedure prevention of angioedema attacks in adults, adolescents and children (2 years old and above) with hereditary angioedema (HAE). Routine prevention of angioedema attacks in adults, adolescents and children (6 years old and above) with severe and recurrent attacks of hereditary angioedema (HAE), who are intolerant to or insufficiently protected by oral prevention treatments, or patients who are inadequately managed with repeated acute treatment.
⚠️ Sicurezza del paziente
No
📚 Avvisi passati (2)
Pagina ufficiale EMA
https://www.ema.europa.eu/en/medicines/human/EPAR/cinryze